Abbott Laboratories is recalling 1,863 units of Spectinomycin Dihydrochloride Pentahydrate, an injectable antibiotic ingredient used for veterinary purposes. This recall was initiated because the active pharmaceutical ingredient (API) was found to be contaminated with Aspergillus mold. Consumers and veterinarians should be aware that this product is intended for manufacturing, processing, or repacking into finished veterinary medications.
The presence of Aspergillus mold in a pharmaceutical product can cause serious fungal infections in animals, particularly if the finished medication is administered via injection. Such infections can lead to severe illness or death, especially in animals with compromised immune systems.
Veterinary Drug Recall Remedy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response